-
September 13, 2012
Carmaker’s gift boosts childhood cancer research
Patrick Grohar, M.D., Ph.D., was awarded a $250,000 Hyundai Hope on Wheels grant last week for his research into potential drug therapies for Ewing sarcoma, a cancer of the bone. -
August 30, 2012
Vanderbilt-led study reveals racial disparities in prostate cancer care
Racial differences exist in quality surgical care, new research from VICC finds. -
August 23, 2012
Gene linked to familial prostate cancer
A rare, inherited mutation confers an eightfold increased risk of prostate cancer, a recent study shows. -
August 16, 2012
Method may refine personalized trials for cancer therapy
A new tool to observe cell behavior has revealed surprising clues about how cancer cells respond to therapy, and may offer a way to further refine personalized cancer treatments. -
August 9, 2012
Study links rare genetic marker to brain cancer
Investigators from Vanderbilt-Ingram Cancer Center and three other cancer centers have identified a link between a rare genetic variant and the risk of developing glioma. -
August 9, 2012
Young patient’s cancer battle inspires hometown
Maryville, Tenn., tucked in the foothills of the Great Smoky Mountains, has a population of just 27,000, but it seemed like every one of its residents rallied around 20-year-old Brently Mancini when he was diagnosed with a rare soft tissue cancer. -
August 2, 2012
Arteaga named to Komen scientific advisory board
Carlos Arteaga, M.D., associate director for Clinical Research and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been named to the Scientific Advisory Board of the Susan G. Komen for the Cure Breast Cancer Research Foundation.
